The LEAP Checklist for Laboratory Evaluation and Analytical Performance Characteristics Reporting of Clinical Measurement Procedures.

Checklist Emerging technology International Federation of Clinical Chemistry and Laboratory Medicine Method Protocol Validation Verification

Journal

Annals of laboratory medicine
ISSN: 2234-3814
Titre abrégé: Ann Lab Med
Pays: Korea (South)
ID NLM: 101571172

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 31 08 2023
revised: 31 08 2023
accepted: 07 09 2023
medline: 7 11 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

Reporting a measurement procedure and its analytical performance following method evaluation in a peer-reviewed journal is an important means for clinical laboratory practitioners to share their findings. It also represents an important source of evidence base to help others make informed decisions about their practice. At present, there are significant variations in the information reported in laboratory medicine journal publications describing the analytical performance of measurement procedures. These variations also challenge authors, readers, reviewers, and editors in deciding the quality of a submitted manuscript. The International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Method Evaluation Protocols (IFCC WG-MEP) developed a checklist and recommends its adoption to enable a consistent approach to reporting method evaluation and analytical performance characteristics of measurement procedures in laboratory medicine journals. It is envisioned that the Laboratory Evaluation and Analytical Performance Characteristics (LEAP) checklist will improve the standardisation of journal publications describing method evaluation and analytical performance characteristics, improving the quality of the evidence base that is relied upon by practitioners.

Identifiants

pubmed: 37869780
pii: alm.2023.0342
doi: 10.3343/alm.2023.0342
pmc: PMC10628757
doi:

Types de publication

Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-125

Références

EJIFCC. 2018 Jul 11;29(2):129-137
pubmed: 30050396
Clin Chem Lab Med. 2015 May;53(6):833-5
pubmed: 25719329
Clin Chem Lab Med. 2023 Jun 14;61(12):2102-2114
pubmed: 37314970
Ann Clin Biochem. 2019 Mar;56(2):275-282
pubmed: 30674211
Scand J Clin Lab Invest. 2012 Apr;72(2):89-91
pubmed: 22339367
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519

Auteurs

Tze Ping Loh (TP)

Department of Laboratory Medicine, National University Hospital, Singapore.

Brian R Cooke (BR)

Department of Clinical Biochemistry, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia.

Thi Chi Mai Tran (TCM)

Faculty of Medical Technology, Hanoi Medical University, Ha Noi, Vietnam.
Department of Clinical Biochemistry, National Children's Hospital, Hanoi, Vietnam.

Corey Markus (C)

Flinders University International Centre for Point-of-Care Testing, Flinders Health and Medical Research Institute, Adelaide, Australia.

Rosita Zakaria (R)

Department of Laboratory Medicine, School of Health and Biomedical Sciences, RMIT University, Victoria, Australia.
Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Chung Shun Ho (CS)

Biomedical Mass Spectrometry Unit, Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.

Elvar Theodorsson (E)

Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linkoping University, Linkoping, Sweden.

Ronda F Greaves (RF)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH